Home › Mga Autoimmune na Sakit › Maryland
Pag-aaral pangklinika para sa Mga Autoimmune na Sakit sa Maryland
21 pag-aaral para sa Mga Autoimmune na Sakit ang naghahanap ng mga kalahok sa mga site sa Maryland.
Mga Lungsod sa Maryland
Opisyal na teksto ng pag-aaral (English)
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT00867269NIAID Centralized Sequencing Protocol
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 100 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03206099Natural History of Bronchiectasis
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 hanggang 100 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT00943514Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 4 hanggang 69 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04339777Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01276470Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 4 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT02579967Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04097561Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 99 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00001350Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
1 Month – 100 Years · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00246857Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- National Naval Medical Center, Bethesda
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT00977977A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- American Oncology Partners of Maryland, PA, Bethesda
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Johns Hopkins Hospital: Division of Rheumatology, Baltimore
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
- Johns Hopkins University, Baltimore
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05671757A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
- The Johns Hopkins Hospital, Baltimore
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07182227A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05027945A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 3 hanggang 99 · Lahat ng kasarian · Na-update Mar 9, 2026 · NCT04304820X-linked Moesin Associated Immunodeficiency
- National Institutes of Health, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 4 hanggang 80 · Kalalakihan · Na-update Abr 25, 2025 · NCT06278337Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.